# THORA (NCT02041845)

> Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02041845
- Phase: NA
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Norwegian University of Science and Technology
- Conditions: Small Cell Lung Carcinoma
- Interventions: 45 Gy in 30 fractions; 60 Gy in 40 fractions
- Enrollment: 177
- Primary outcome: survival

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3
- Podcasts: 1

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=thora-nct02041845